OTCMKTS:RCDTF Recordati Industria Chimica E Farmaceutica (RCDTF) Stock Price, News & Analysis $58.00 0.00 (0.00%) As of 09/15/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsShort Interest About Recordati Industria Chimica E Farmaceutica Stock (OTCMKTS:RCDTF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get RCDTF alerts:Sign Up Key Stats Today's Range$58.00▼$58.0050-Day Range$58.00▼$58.0052-Week Range$55.88▼$60.00VolumeN/AAverage Volume1 shsMarket Capitalization$11.97 billionP/E Ratio20.68Dividend YieldN/APrice TargetN/AConsensus RatingBuy Company Overview Recordati Industria Chimica e Farmaceutica S.p.A. is an Italy-based pharmaceutical company focused on the research, development, manufacture and commercialization of prescription medicines. Its business is centered on specialty-care and rare-disease treatments, as well as selected products for primary care and other therapeutic areas. The company’s portfolio includes medicines for conditions such as endocrine disorders, cardiovascular disease, central nervous system disorders and rare diseases. Recordati markets both proprietary products and established branded medicines, including treatments based on active ingredients such as osilodrostat, cariprazine and lercanidipine. Its rare-disease operations expanded through the acquisition of EUSA Pharma, which added products for specialized and orphan indications. Founded in Italy in 1926 by Giovanni Recordati, the company has developed from a domestic pharmaceutical business into an international group. Recordati serves healthcare markets across Europe and in other regions, including the United States and selected countries in the Middle East, North Africa and Latin America. The group is headquartered in Milan, Italy, and is led by Chief Executive Officer Rob Koremans, with Andrea Recordati serving as chairman.AI Generated. May Contain Errors. Read More Receive RCDTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Recordati Industria Chimica E Farmaceutica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCDTF Stock News HeadlinesIl piccolo azionista deve sapere queste cose prima dell'OPA di Recordati del 31 agostoAugust 26, 2026 | msn.comRecordati, il cda approva l’opas: “Nessun rilancio, prezzo congruo”. Ma gli indipendenti dicono noJuly 16, 2026 | msn.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 16 at 1:00 AM | Stansberry Research (Ad)Recordati, il cda si spacca sull'opa. Gli indipendenti bocciano il prezzo, via libera con sei voti su dieciJuly 16, 2026 | msn.comCVC, GBL launch €10.7 billion bid for Italian drugmaker RecordatiMay 22, 2026 | reuters.comRecordati SpA (RCDTF) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and R&D ...May 15, 2026 | uk.finance.yahoo.comRECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%May 12, 2026 | markets.businessinsider.comKepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)April 23, 2026 | theglobeandmail.comSee More Headlines RCDTF Stock Analysis - Frequently Asked Questions How have RCDTF shares performed this year? Recordati Industria Chimica E Farmaceutica's stock was trading at $65.44 on January 1st, 2026. Since then, RCDTF shares have decreased by 11.4% and is now trading at $58.00. How were Recordati Industria Chimica E Farmaceutica's earnings last quarter? Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) released its quarterly earnings data on Wednesday, July, 29th. The company reported $0.91 earnings per share for the quarter. The business earned $810.70 million during the quarter. Recordati Industria Chimica E Farmaceutica had a net margin of 18.38% and a trailing twelve-month return on equity of 33.73%. How do I buy shares of Recordati Industria Chimica E Farmaceutica? Shares of RCDTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings7/29/2026Today9/16/2026Next Earnings (Estimated)11/10/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:RCDTF Previous SymbolNASDAQ:RCDTF CIKN/A Webwww.recordati.com Phone390-248-7871Fax39-02-4007-3747Employees4,693Year Founded1926Profitability EPS (Trailing Twelve Months)$2.80 Trailing P/E Ratio20.68 Forward P/E RatioN/A P/E GrowthN/ANet Income$501.92 million Net Margins18.38% Pretax Margin22.20% Return on Equity33.73% Return on Assets12.76% Debt Debt-to-Equity Ratio0.79 Current Ratio1.26 Quick Ratio0.86 Sales & Book Value Annual Sales$2.96 billion Price / Sales4.04 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares206,300,000Free FloatN/AMarket Cap$11.97 billion OptionableNot Optionable Beta0.25 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:RCDTF) was last updated on 9/16/2026 by MarketBeat.com Staff. From Our PartnersA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...Paradigm Press | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredTSM just handed Trump's secretive AI project $100 billion — See this before September 29Taiwan Semiconductor just pledged another $100 billion to US chip manufacturing, bringing its total US investm...InvestorPlace | SponsoredIran War SHOCK: My Source Told Me to Watch for ThisA Middle Eastern government just asked Trump for military help against Iran-backed forces. One analyst says...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recordati Industria Chimica E Farmaceutica S.P.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recordati Industria Chimica E Farmaceutica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCDTF Stock Alerts